POCT is the fastest growing segment of laboratory diagnostics in Europe. It is performed using electronic and non-electronic devices that range from reaction strips to bulky devices. These devices replace a series of laboratory experiments and reduce the turnaround time. POCT diagnostic devices can be categorized into hand-held and near-bedside monitoring devices. The hand-held POCT devices are small, offering mobility while the near-bedside POCT devices are larger and complex. For both the devices, quality control and calibration functionality are checked before performing the tests.
Technavio’s analysts forecast the POCT market in Europe to grow at a CAGR of 4.07% during the period 2016-2020.
Covered in this report The report covers the present scenario and the growth prospects of the point-of-care testing (POCT) market in Europe for the period 2015-2019. To calculate the market size, the report considers the revenue generated from sales of POCT diagnostic devices, including instruments and consumables
The market is divided into the following segments based on application: - Blood glucose testing - Infectious diseases testing - Cardiac markers testing - Coagulation testing - Pregnancy and fertility testing - Electrolyte testing - Tumor markers testing - Urinalysis - Cholesterol testing
Technavio's report, POCT Market in Europe 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key vendorsoperating in this market.
Market driver - Patient-driven demand - For a full, detailed list, view our report
Market challenge - Direct-to-consumer genetic testing - For a full, detailed list, view our report
Market trend - Government initiatives for quality improvement - For a full, detailed list, view our report
Key questions answered in this report - What will the market size be in 2020 and what will the growth rate be? - What are the key market trends? - What is driving this market? - What are the challenges to market growth? - Who are the key vendors in this market space? - What are the market opportunities and threats faced by the key vendors? - What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Our reports have been used by over 10K customers, including:
The global in-vitro diagnostics market size is projected to reach USD 96.0 billion by 2025 from USD 84.5 billion in 2020, at a CAGR of 2.6% during the forecast period. Market growth is attributed to the rising per capita income in developed and developing countries and technological advancements introduced in the in-vitro diagnostic devices. By...
The United States In Vitro Diagnostics (IVD) market is predicted to reach nearly US$ 37 Billion by 2026. In-vitro Diagnostics (IVD) serves a key role in the healthcare value chain by significantly influencing the quality of health outcomes, patient treatment, care and downstream resource requirements. With an aging population, technological...
Global In Vitro Diagnostic Market to Reach $113.86 Billion by 2030 Market Report Coverage - In Vitro Diagnostic Market Segmentation • Product – Instruments, Consumables, and Software • Test Type – Immunoassay, Clinical Chemistry, Whole Blood Glucose Monitoring, Molecular Diagnostics,...
Summary Proteomics International Laboratories Ltd (Proteomics) operates as a medical technology company that discovers new biopharmaceutical drugs.The company harnesses its proprietary proteomics-based technology platform to work in three integrated areas; diagnostics, analytical services and drug discovery. Proteomics...
The global in-vitro diagnostics market is expected to be valued at USD 61.0 billion in 2020, growing at a CAGR of 6.5% during 2020-2025. The global in-vitro diagnostics market size is expected to be valued at USD 61.0 billion in 2020, growing at a CAGR of 6.5% during 2020-2025. The demand for in-vitro diagnostic products due to the...
The global IVD quality control market is projected to grow at a CAGR of 3.8%. The global IVD quality control market size is projected to reach USD 1,158 million by 2025 from USD 961 million in 2020, at a CAGR of 3.8% during the forecast period. The market for IVD quality control is primarily driven by the increasing number of accredited...
China In-Vitro Diagnostics (IVD) market is likely to reach around US$ 17.6 Billion by 2026. China represents one of the largest clinical laboratory markets in the Asia-Pacific region, and the fastest growing among the top ten IVD country markets. Historically, large multinational companies have dominated IVD market in China; today, domestic...
The India household insecticides market is accounted to US$ 1,147.5 Mn in 2018 and is expected to grow at a CAGR of 5.4% during the forecast period 2019 - 2027, to account for US$ 1,829.6 Mn by 2027. The household insecticides market has been witnessing a remarkable growth in India from the last few years. Household insecticide products are...
Executive Summary Global In Vitro Diagnostics Market was valued at USD 61700.22 Million in the year 2018. As size of old age population is increasing globally, quality healthcare is required. Diagnostics have major role, as majority of clinical decisions are based on diagnostic test result. They assist in providing personalised...
Nanomedicine Market Size, Outlook and Growth Opportunities, 2019- 2025 Global Nanomedicine Market size, Outlook and Opportunities 2019- 2025: By Modality (Treatments and Diagnostics), By Product (Therapeutics, In-vivo diagnostics, In-vitro diagnostics, Vaccines and Regenerative medicine), By Application (Clinical Oncology,...
In Vitro Diagnostics
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.